speb/financial-data huggingface dataset:
FLTR.L balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 3432000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 3455000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Cash Equivalents: 1920000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Cash Financial: 1512000000.00
FLTR.L cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 20000000.00
FLTR.L cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -167000000.00
FLTR.L cash_flow (quarterly, 2026-03-31) — Change In Payable: 65000000.00
FLTR.L cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -48000000.00
FLTR.L cash_flow (quarterly, 2026-03-31) — Change In Receivables: 32000000.00
FLTR.L cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -98000000.00
FLTR.L cash_flow (quarterly, 2026-03-31) — Changes In Cash: -300000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Common Stock: 36000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 9064000000.00
FLTR.L cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 4000000.00
FLTR.L cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -135000000.00
FLTR.L income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 2467000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Current Assets: 4500000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 153000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Current Debt: 171000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 324000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 4980000000.00
FLTR.L cash_flow (quarterly, 2026-03-31) — Deferred Tax: -37000000.00
FLTR.L cash_flow (quarterly, 2026-03-31) — Depreciation: 416000000.00
FLTR.L cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 416000000.00
FLTR.L income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 177235772.00
FLTR.L income_statement (quarterly, 2026-03-31) — Diluted EPS: 1.23
FLTR.L income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 218000000.00
FLTR.L income_statement (quarterly, 2026-03-31) — EBIT: 401000000.00
FLTR.L income_statement (quarterly, 2026-03-31) — EBITDA: 817000000.00
FLTR.L cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -27000000.00
FLTR.L cash_flow (quarterly, 2026-03-31) — End Cash Position: 3505000000.00
FLTR.L cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -458000000.00
FLTR.L cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 153000000.00
FLTR.L cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 2000000.00
FLTR.L income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 533000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Goodwill: 15649000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 22363000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Gross PPE: 1135000000.00
FLTR.L income_statement (quarterly, 2026-03-31) — Gross Profit: 1837000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Hedging Assets Current: 58000000.00
FLTR.L income_statement (quarterly, 2026-03-31) — Interest Expense: 167000000.00
FLTR.L income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 167000000.00
FLTR.L income_statement (quarterly, 2026-03-31) — Interest Income: 11000000.00
FLTR.L income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 11000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Invested Capital: 21029000000.00
FLTR.L cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -172000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 6000000.00
FLTR.L cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 4000000.00
FLTR.L cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 450000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 442000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 11794000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 12236000000.00
FLTR.L cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 450000000.00
FLTR.L cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -744000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Minority Interest: 645000000.00
FLTR.L income_statement (quarterly, 2026-03-31) — Minority Interests: 7000000.00
FLTR.L cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -131000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Net Debt: 8533000000.00
FLTR.L cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -20000000.00
FLTR.L income_statement (quarterly, 2026-03-31) — Net Income: 216000000.00
FLTR.L income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 218000000.00
FLTR.L income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 209000000.00
FLTR.L income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 216000000.00
FLTR.L income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 216000000.00
FLTR.L cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 209000000.00
FLTR.L income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 209000000.00
FLTR.L cash_flow (quarterly, 2026-03-31) — Net Intangibles Purchase And Sale: -32000000.00
FLTR.L income_statement (quarterly, 2026-03-31) — Net Interest Income: -156000000.00
FLTR.L cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 5000000.00
FLTR.L cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -294000000.00
FLTR.L cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -294000000.00
FLTR.L income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -156000000.00
FLTR.L cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -15000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Net PPE: 1135000000.00
FLTR.L cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -25000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -13299000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 295000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 1038000000.00
FLTR.L income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 526000000.00
FLTR.L income_statement (quarterly, 2026-03-31) — Normalized Income: -43863000.00
FLTR.L cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 330000000.00
FLTR.L income_statement (quarterly, 2026-03-31) — Operating Income: 79000000.00
FLTR.L income_statement (quarterly, 2026-03-31) — Operating Revenue: 4304000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 174400428.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 1936000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 6714000000.00
FLTR.L cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -191000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 175000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 511000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Other Properties: 1135000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Other Receivables: 540000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 23000000.00
FLTR.L income_statement (quarterly, 2026-03-31) — Other Special Charges: 2000000.00
FLTR.L income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: -2000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Payables: 1141000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 388000000.00
FLTR.L income_statement (quarterly, 2026-03-31) — Pretax Income: 234000000.00
FLTR.L cash_flow (quarterly, 2026-03-31) — Purchase Of Intangibles: -32000000.00
FLTR.L cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -25000000.00
FLTR.L income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 2467000000.00
FLTR.L income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 416000000.00
FLTR.L cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -744000000.00
FLTR.L cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -135000000.00
FLTR.L income_statement (quarterly, 2026-03-31) — Research And Development: 259000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 73000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 8231000000.00
FLTR.L cash_flow (quarterly, 2026-03-31) — Sale Of Intangibles: 0.00
FLTR.L cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 5000000.00
FLTR.L income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 966000000.00
FLTR.L income_statement (quarterly, 2026-03-31) — Selling General And Administration: 1499000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Share Issued: 174400428.00
FLTR.L income_statement (quarterly, 2026-03-31) — Special Income Charges: -2000000.00
FLTR.L cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 49000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 9064000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -13299000000.00
FLTR.L income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 31137000.00
FLTR.L income_statement (quarterly, 2026-03-31) — Tax Provision: 25000000.00
FLTR.L income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.11
FLTR.L balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 219000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Total Assets: 28474000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 20858000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Total Debt: 12560000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 9709000000.00
FLTR.L income_statement (quarterly, 2026-03-31) — Total Expenses: 4225000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 18765000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 23974000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 13785000000.00
FLTR.L income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 79000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 714000000.00
FLTR.L income_statement (quarterly, 2026-03-31) — Total Unusual Items: 291000000.00
FLTR.L income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 291000000.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 0.00
FLTR.L balance_sheet (quarterly, 2026-03-31) — Working Capital: -480000000.00
FLUOROCHEM.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -11191332000.00
FLUOROCHEM.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -110585000.00
FLUOROCHEM.NS income_statement (annual, 2022-03-31) — Amortization: 54600000.00
FLUOROCHEM.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 54600000.00
FLUOROCHEM.NS balance_sheet (annual, 2022-03-31) — Assets Held For Sale Current: 0.00
FLUOROCHEM.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 3517254000.00
FLUOROCHEM.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 255482000.00
FLUOROCHEM.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 219700000.00
FLUOROCHEM.NS balance_sheet (annual, 2022-03-31) — Financial Assets: 11155000.00
FLUOROCHEM.NS balance_sheet (annual, 2022-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 0.00
FLUOROCHEM.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 4245615000.00
FLUOROCHEM.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 732294000.00
FLUOROCHEM.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 7891502000.00
FLUOROCHEM.NS income_statement (annual, 2022-03-31) — Interest Income: 817303000.00
FLUOROCHEM.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 817303000.00
FLUOROCHEM.NS balance_sheet (annual, 2022-03-31) — Investmentsin Joint Venturesat Cost: 8681000.00
FLUOROCHEM.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 450741000.00
FLUOROCHEM.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 32079926000.00
FLUOROCHEM.NS cash_flow (annual, 2022-03-31) — Net Investment Properties Purchase And Sale: 227700000.00
FLUOROCHEM.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 328926000.00
FLUOROCHEM.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 153662000.00
FLUOROCHEM.NS balance_sheet (annual, 2022-03-31) — Other Inventories: 180906000.00
FLUOROCHEM.NS balance_sheet (annual, 2022-03-31) — Other Payable: 1598316000.00
FLUOROCHEM.NS income_statement (annual, 2022-03-31) — Other Special Charges: -137972000.00
FLUOROCHEM.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 161303000.00
FLUOROCHEM.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 1288413000.00
FLUOROCHEM.NS balance_sheet (annual, 2022-03-31) — Properties: 120872000.00
FLUOROCHEM.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 4001381000.00
FLUOROCHEM.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 225683000.00
FLUOROCHEM.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 225683000.00
FLUOROCHEM.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 9055224000.00
FLUOROCHEM.NS cash_flow (annual, 2022-03-31) — Sale Of Investment Properties: 227700000.00
FLUOROCHEM.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 1449641000.00
FLUOROCHEM.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 2181935000.00
FLUOROCHEM.NS balance_sheet (annual, 2022-03-31) — Taxes Receivable: 304916000.00
FLUOROCHEM.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 16506000.00
FLUOROCHEM.NS balance_sheet (annual, 2022-03-31) — Tradeand Other Payables Non Current: 122956000.00
FLUOROCHEM.NS balance_sheet (annual, 2022-03-31) — Work In Process: 1044674000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — +Operating Expense: 21334468000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — +Total Revenue: 55942403000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 6910026000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 11067972000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -13411499000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -107552000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Amortization: 57432000.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 57432000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Assets Held For Sale Current: 266894000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 9270000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 109850000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Basic EPS: 120.97
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 255482000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 4065542000.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -7313329000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 368793000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 109850000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 239911000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 2123941000.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -439400000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 239911000.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Change In Inventory: -5381212000.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: -2297527000.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: 155114000.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Change In Payable: 1771389000.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -3165426000.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -8826766000.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Changes In Cash: -15571000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Common Stock: 109850000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 55207185000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 16222805000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 17311419000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Current Assets: 34978581000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 31986000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Current Debt: 12950253000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 12982239000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 23388985000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 204200000.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Deferred Tax: 4616913000.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Depreciation: 2303092000.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 2360524000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 2360524000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 2303092000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 109850000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Diluted EPS: 120.97
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 13288124000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 2866000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — EBIT: 18833515000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — EBITDA: 21194039000.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — End Cash Position: 239911000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 0.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -2640737000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 7017185000.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 75571000.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: 6298000.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: -26338000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 953879000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 254005000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 11175524000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 60612388000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Gross Profit: 38630984000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Interest Expense: 986143000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 986143000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Interest Income: 631363000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 631363000.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -1335822000.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 350649000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Inventory: 14853789000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 69989617000.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -4763734000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Investment Properties: 33818000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 9270000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Investmentsin Joint Venturesat Cost: 8629000.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 2000000000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 987223000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 336807000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 1832179000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 2168986000.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 2000000000.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -5431263000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 8629000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 395400000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 39135275000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Minority Interest: 0.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Minority Interests: 57665000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Net Debt: 14542521000.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: 61911000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Net Income: 13288124000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 13288124000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 13230459000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 13288124000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 13288124000.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 13230459000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 13230459000.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Net Intangibles Purchase And Sale: -42165000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Net Interest Income: -373117000.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Net Investment Properties Purchase And Sale: 0.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 2149593000.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: -795912000.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: -3431263000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -373117000.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Net Other Financing Charges: -36766000.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: 1958200000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Net PPE: 47200889000.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -7221811000.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: 2635351000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 54953180000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 2862000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 2412985000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 395385000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 1173363000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 21173999000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Normalized Income: 13273268121.03
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 7388900000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Operating Income: 17296516000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Operating Revenue: 55942403000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 109850000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 475942000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 316200000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 55097300000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 254005000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Other Inventories: 499510000.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 501548000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 5808500000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 237752000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 12748288000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Other Payable: 2442537000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Other Properties: 61551000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 3480678000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 1884030000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Other Special Charges: -26338000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Payables: 10113606000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 204190000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 1443064000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Pretax Income: 17847372000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Properties: 139992000.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 125282000.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Purchase Of Intangibles: -42165000.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -1049946000.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -7271164000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 5744234000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 17311419000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 2360524000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 435068000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 435068000.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -5431263000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 21558423000.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 3199539000.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Sale Of Investment Properties: 0.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 49353000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 1857950000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 2811829000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Share Issued: 109850000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Special Income Charges: 26338000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 55207185000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 54953180000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 5184121.03
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Tax Provision: 4616913000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.26
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 1742243000.00
FLUOROCHEM.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -4699565000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Total Assets: 83713873000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 57039364000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Total Debt: 15151225000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 55207185000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Total Expenses: 38645887000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 28506688000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 48735292000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 5117703000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 18337000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 758177000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 20040000.00
FLUOROCHEM.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 20040000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Tradeand Other Payables Non Current: 140347000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Work In Process: 1592860000.00
FLUOROCHEM.NS balance_sheet (annual, 2023-03-31) — Working Capital: 11589596000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — +Operating Expense: 19878700000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — +Total Revenue: 41936700000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 5189200000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 8445900000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -16203800000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 0.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -100400000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Amortization: 61800000.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 61800000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Assets Held For Sale Current: 0.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 9500000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 109850000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Basic EPS: 39.59
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 239900000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 7721800000.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -9705700000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 1001700000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 109900000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 314500000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 808600000.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -219700000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 314500000.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -859600000.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -1492000000.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: -350200000.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Change In Payable: -1636200000.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Change In Receivables: 2786100000.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -1440000000.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 74500000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Common Stock: 109900000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 59363400000.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Common Stock Issuance: 0.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 12991700000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 15764200000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Current Assets: 34035500000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 103800000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Current Debt: 16227000000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 16330800000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 25028200000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 196800000.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Deferred Tax: 1601300000.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Depreciation: 2799300000.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 2861100000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 2861000000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 2799200000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 109850000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Diluted EPS: 39.59
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 4349500000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 3700000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — EBIT: 7186300000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — EBITDA: 10047400000.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — End Cash Position: 314400000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 0.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: 3475700000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 7769000000.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: -3442300000.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: 200000.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of Business: 0.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: 74000000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 975300000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 460200000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 8546300000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 71715500000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Gross Profit: 26172500000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Interest Expense: 1235400000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 1235400000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Interest Income: 276500000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 276500000.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -1405600000.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 190700000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Inventory: 15713400000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 79321200000.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -9664600000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Investment Properties: 33000000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 9500000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Investmentsin Joint Venturesat Cost: 8600000.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 0.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 3126900000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 1056300000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 897900000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 3730800000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 4628700000.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 3126900000.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -1094800000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Long Term Equity Investment: 8600000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 544900000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 49739000000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Minority Interest: 0.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Minority Interests: 0.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Net Business Purchase And Sale: 0.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 0.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Net Debt: 19643300000.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: -114200000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Net Income: 4349500000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 4349500000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 4349500000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 4349500000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 4349500000.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 4349500000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 4349500000.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Net Intangibles Purchase And Sale: -113000000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Net Interest Income: -961000000.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: 1600000.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 5190800000.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 2032100000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -961000000.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Net Other Investing Changes: -296900000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Net PPE: 55511700000.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -9447000000.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: 3158700000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 58903200000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 10300000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 2664600000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 544800000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 1348000000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 10121600000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Normalized Income: 4403732620.28
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 6263400000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Operating Income: 6293800000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Operating Revenue: 41936700000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 109850000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 231132000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 344400000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 59253500000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 460200000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Other Inventories: 143300000.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 887300000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 4016800000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 311700000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 10738600000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Other Payable: 2865800000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Other Properties: 62200000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 3651800000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 494100000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Other Special Charges: 74000000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Payables: 8438400000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 196800000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 1034400000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Pretax Income: 5950900000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Properties: 144500000.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: -7100000.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Purchase Of Business: 0.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Purchase Of Intangibles: -113000000.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: 0.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -9592700000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 5634100000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 15764200000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 2861100000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 413500000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 432500000.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: -1094800000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 1653400000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 25665100000.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Sale Of Business: 0.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 1600000.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 145700000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 1600600000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 2575900000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Share Issued: 109850000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Special Income Charges: -74000000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 59363400000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 58903200000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: -19967379.72
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Tax Provision: 1601400000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.27
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 2728000000.00
FLUOROCHEM.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -1949400000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Total Assets: 92340700000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 63094200000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Total Debt: 20959500000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 59363400000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Total Expenses: 35642900000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 32977300000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 58305200000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 7949100000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 2100000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 379700000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Total Unusual Items: -74200000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: -74200000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Tradeand Other Payables Non Current: 111000000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Work In Process: 2167000000.00
FLUOROCHEM.NS balance_sheet (annual, 2024-03-31) — Working Capital: 9007300000.00
FLUOROCHEM.NS income_statement (annual, 2024-03-31) — Write Off: 0.00
FLUOROCHEM.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 4950000000.00
FLUOROCHEM.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 9210000000.00
FLUOROCHEM.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 210000000.00
FLUOROCHEM.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 960000000.00
FLUOROCHEM.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 110000000.00
FLUOROCHEM.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 530000000.00
FLUOROCHEM.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 5390000000.00
FLUOROCHEM.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 110000000.00
FLUOROCHEM.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 61390000000.00
FLUOROCHEM.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 11150000000.00
FLUOROCHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 34290000000.00
FLUOROCHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 110000000.00
FLUOROCHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 16030000000.00
FLUOROCHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 16140000000.00
FLUOROCHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 24490000000.00
FLUOROCHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 170000000.00
FLUOROCHEM.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 730000000.00
FLUOROCHEM.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 55300000000.00
FLUOROCHEM.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 15820000000.00
FLUOROCHEM.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 82220000000.00
FLUOROCHEM.NS balance_sheet (quarterly, 2024-09-30) — Investment Properties: 30000000.00